Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ABBOTT LABORATORIES

Get SEC filing alerts via email and in your feed for ABBOTT LABORATORIES

ABT

ABBOTT LABORATORIES

About ABBOTT LABORATORIES

Abbott Laboratories is a global healthcare company focused on the discovery, development, and manufacturing of a diverse range of healthcare products. Its key segments include Established Pharmaceuticals, Diagnostic Products, Nutritional Products, and Medical Devices. Targeting healthcare providers and consumers, Abbott capitalizes on significant market opportunities in emerging markets. The company emphasizes innovation and technological advancements, particularly in diagnostics and medical devices, to enhance patient care and health outcomes worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ABBOTT LABORATORIES

1
1
ABBOTT LABORATORIES Abbott Laboratories Reports 7.8% Sales Increase but Declines in Net Earnings in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
ABBOTT LABORATORIES Abbott Laboratories Reports $44.3 Billion in Net Sales for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
ABBOTT LABORATORIES Abbott Laboratories Reports 6.9% Revenue Growth in Q3 2025, Driven by Medical Devices and Pharmaceuticals

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ABBOTT LABORATORIES Abbott Laboratories Reports 7.4% Revenue Growth to $11.1 Billion in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ABBOTT LABORATORIES Abbott Laboratories Reports 4.6% Net Sales Increase to $41.95 Billion for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

6
1
ABBOTT LABORATORIES Abbott Laboratories Reports Strong Q3 and Nine-Month Financial Performance with 4.9% Sales Growth

Via official filing (AI summary) | over 1 year ago | 0 comments